Molecular Data Statistics
Total Valuation
Molecular Data has a market cap or net worth of 12.
Market Cap | 12 |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Molecular Data has 12.18 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 12.18M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93
Current Ratio | 0.93 |
Quick Ratio | 0.55 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -43.34 |
Financial Efficiency
Return on equity (ROE) is -4,936.16% and return on invested capital (ROIC) is -168.48%.
Return on Equity (ROE) | -4,936.16% |
Return on Assets (ROA) | -21.43% |
Return on Capital (ROIC) | -168.48% |
Revenue Per Employee | 3.79M |
Profits Per Employee | -209,626 |
Employee Count | 189 |
Asset Turnover | 5.98 |
Inventory Turnover | 1,286.58 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.90% in the last 52 weeks. The beta is 1.38, so Molecular Data's price volatility has been higher than the market average.
Beta (5Y) | 1.38 |
52-Week Price Change | -99.90% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 39.43 |
Average Volume (20 Days) | 1,774 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 7.58 |
Income Statement
In the last 12 months, Molecular Data had revenue of 715.39 million and -39.62 million in losses. Loss per share was -4.00.
Revenue | 715.39M |
Gross Profit | -414,737 |
Operating Income | -41.03M |
Pretax Income | -39.36M |
Net Income | -39.62M |
EBITDA | -40.14M |
EBIT | -41.03M |
Loss Per Share | -4.00 |
Balance Sheet
The company has 54.09 million in cash and 15.80 million in debt, giving a net cash position of 38.28 million or 3.14 per share.
Cash & Cash Equivalents | 54.09M |
Total Debt | 15.80M |
Net Cash | 38.28M |
Net Cash Per Share | 3.14 |
Equity (Book Value) | -9.11M |
Book Value Per Share | -0.93 |
Working Capital | -8.97M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is -0.06%, with operating and profit margins of -5.73% and -5.54%.
Gross Margin | -0.06% |
Operating Margin | -5.73% |
Pretax Margin | -5.50% |
Profit Margin | -5.54% |
EBITDA Margin | -5.61% |
EBIT Margin | -5.73% |
FCF Margin | n/a |
Dividends & Yields
Molecular Data does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on May 23, 2022. It was a reverse split with a ratio of 0.0666667.
Last Split Date | May 23, 2022 |
Split Type | Reverse |
Split Ratio | 0.0666667 |
Scores
Molecular Data has an Altman Z-Score of 3.54.
Altman Z-Score | 3.54 |
Piotroski F-Score | n/a |